The organisation
referred to in regulation 29I(2)(a) must —
(a) test
the sample for the presence of the infectious disease named in the test
authorisation notice; and
(b)
notify the chief executive officer of the results of the test.
[Regulation 29J inserted: SL 2020/251
r. 4.]